Roger Rivera
Psychiatric/Mental Health · Kissimmee, FLNPI 1730697715
Payments from drug & device makers
Across 2,401 payments — averaging $657.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$632K
- Alkermes, Inc.$415K
- Vanda Pharmaceuticals Inc.$172K
- Axsome Therapeutics, Inc.$147K
- Neurocrine Biosciences, Inc.$84K
- Teva Pharmaceuticals USA, Inc.$56K
- plus $75K from 15 others
What the payments were for
- Consulting fees$75,9715%
- Speaking & faculty fees$1,026,49765%
- Travel & lodging$433,00527%
- Food & beverage$44,1753%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 880 | $631,580 |
| Alkermes, Inc. | 708 | $414,564 |
| Vanda Pharmaceuticals Inc. | 225 | $171,519 |
| Axsome Therapeutics, Inc. | 236 | $147,297 |
| Neurocrine Biosciences, Inc. | 104 | $83,602 |
| Teva Pharmaceuticals USA, Inc. | 62 | $56,118 |
| E.r. Squibb & Sons, L.L.C. | 53 | $27,252 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 48 | $23,778 |
| Otsuka America Pharmaceutical, Inc. | 35 | $13,348 |
| Idorsia Pharmaceuticals US Inc | 18 | $8,423 |
| Janssen Scientific Affairs, LLC | 1 | $1,450 |
| Johnson & Johnson | 14 | $334 |
| Supernus Pharmaceuticals, Inc. | 2 | $99 |
| CSL Behring | 1 | $91 |
| Sunovion Pharmaceuticals Inc. | 5 | $54 |
| Ironshore Pharmaceuticals Inc. | 3 | $52 |
| Corium, LLC | 1 | $35 |
| Indivior Inc. | 2 | $34 |
| Eisai Inc. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,579,680 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 22 | $167,378 |
| VraylarCariprazine Hcl | 65 | $92,333 |
| LybalviOlanzapine/Samidorphan Malate | 56 | $88,193 |
| FanaptIloperidone | 30 | $64,124 |
| CaplytaLumateperone Tosylate | 24 | $38,774 |
| AuvelityDextromethorphan Hbr/Bupropion | 30 | $27,235 |
| QuviviqDaridorexant Hcl | 15 | $7,373 |
| BelsomraSuvorexant | 11 | $4,611 |
| Aripiprazole | 11 | $1,012 |
| Duloxetine Hcl | 42 | $769 |
| Quetiapine Fumarate | 35 | $402 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 28 | $359 |
| Alprazolam | 61 | $283 |
| Lurasidone Hcl | 11 | $227 |
| Hydroxyzine Hcl | 24 | $206 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $83,602 | $167,37822 claims |
| AbbVieVraylar | $631,580 | $92,33365 claims |
| Alkermes, Inc.Lybalvi | $414,564 | $88,19356 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $171,519 | $64,12430 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $23,778 | $38,77424 claims |
| Axsome Therapeutics, Inc.Auvelity | $147,297 | $27,23530 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $8,423 | $7,37315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Kissimmee
- Trinese HardyKissimmee$30K
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.